Cite
MLA Citation
Vladimir Neychev et al.. “Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial.” BMJ open, vol. 5, no. 5, 2015, p. . http://access.bl.uk/ark:/81055/vdc_100134879328.0x000009